Incoming BIO CEO Michelle McMurry-Heath (BIO)
May 14, 2020 09:41 AM EDTUpdated 09:51 AM
People
Bioregnum
Opinion

BIO gets a new chief lob­by­ist to face off against the grow­ing ranks of crit­ics in Con­gress

BIO has se­lect­ed its next CEO to suc­ceed James Green­wood as one of biotech’s top lob­by­ists. And she comes with a dream ré­sumé that rings …

Endpoints Premium

This article is available only to Premium subscribers

Upgrade to Premium for unlimited access and Premium exclusives.

UPGRADE
TRENDING NOW

Pfiz­er look­ing to sell hos­pi­tal drugs unit — re­ports

As­traZeneca CEO reaf­firms com­mit­ment to Chi­na fol­low­ing ex­ec­u­tive's de­ten­tion

'Ex­per­tise is a re­al thing': FDA com­mis­sion­er warns of po­lit­i­cal risk to agency

Mer­ck, As­traZeneca tout Phase 3 win for can­cer-turned-rare dis­ease drug

Sanofi, Ope­nAI, For­ma­tion Bio de­but pa­tient re­cruit­ing tool, will use in Phase 3 mul­ti­ple scle­ro­sis stud­ies

sponsored

What Will It Take to Re­verse Fi­bro­sis in Pa­tients with Ad­vanced MASH?

A service from the Financial Times